Article Details

AbbVie joins forces with IGI in $700m deal for trispecific antibody - BioProcess International

Retrieved on: 2025-07-16 21:54:38

Tags for this article:

Click the tags to see associated articles and topics

AbbVie joins forces with IGI in $700m deal for trispecific antibody - BioProcess International. View article details on hiswai:

Excerpt

Multispecific antibody therapies can target multiple cell types simultaneously, giving them benefits over monoclonal antibodies and other more ...

Article found on: www.bioprocessintl.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo